Published in Lancet on August 12, 2000
Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol (2006) 2.06
Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol (2014) 1.70
Hysterectomy and urinary incontinence in postmenopausal women. Int Urogynecol J (2014) 1.43
Prevalence of urinary incontinence in Korean women: results of a National Health Interview Survey. World J Urol (2008) 1.09
The female inferior hypogastric (= pelvic) plexus: anatomical and radiological description of the plexus and its afferences--applications to pelvic surgery. Surg Radiol Anat (2006) 1.05
Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event. BMC Med Res Methodol (2012) 1.01
Risk factors in acquired faecal incontinence. J R Soc Med (2004) 0.93
Classical and nerve-sparing radical hysterectomy: an evaluation of the risk of injury to the autonomous pelvic nerves. Surg Radiol Anat (2003) 0.92
Hysterectomy does not cause constipation. Dis Colon Rectum (2008) 0.91
Prevalence and risk factors of urinary incontinence in Indian women: A hospital-based survey. Indian J Urol (2013) 0.90
Systematization of the vesical and uterovaginal efferences of the female inferior hypogastric plexus (pelvic): applications to pelvic surgery on women patients. Surg Radiol Anat (2007) 0.87
Vaginal hysterectomy and risk of pelvic organ prolapse and stress urinary incontinence surgery. Int Urogynecol J (2011) 0.85
Conventional versus nerve-sparing radical surgery for cervical cancer: a meta-analysis. J Gynecol Oncol (2015) 0.84
Influence of hysterectomy on pelvic-floor dysfunction. Lancet (2000) 0.83
Long-Term Outcomes of the Total or Supracervical Hysterectomy (TOSH) Trial. Female Pelvic Med Reconstr Surg (2010) 0.82
Pregnancy as a risk factor for ambulatory limitation in later life. Am J Public Health (2012) 0.82
Lower urinary tract symptoms in women with pelvic organ prolapse. Int Urogynecol J (2010) 0.81
Predicting the development of stress urinary incontinence 3 years after hysterectomy. Int Urogynecol J (2011) 0.80
Potential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy. Int J Womens Health (2015) 0.80
The impact of hysterectomy on lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct (2003) 0.80
Urinary incontinence after hysterectomy. Lancet (2000) 0.79
Hysterectomy and disability among U.S. women. Perspect Sex Reprod Health (2013) 0.79
Incidence and remission of urinary incontinence after hysterectomy--a 3-year follow-up study. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.78
Prevalence and incidence of urinary incontinence in a diverse population of women with noncancerous gynecologic conditions. Female Pelvic Med Reconstr Surg (2010) 0.78
Is hysterectomy or the use of graft necessary for the reconstructive surgery for uterine prolapse? Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.78
Measuring urinary incontinence in a population of women in northern Mexico: prevalence and severity. Int Urogynecol J (2012) 0.77
Comparison of Incontinence Risk after Radical Prostatectomy versus Hysterectomy. Rev Urol (2001) 0.75
Effects of genital prolapse surgery and hysterectomy on pelvic floor function. Facts Views Vis Obgyn (2009) 0.75
Advantages of nerve-sparing intrastromal total abdominal hysterectomy. Int J Womens Health (2013) 0.75
Incidence and Risk Factors of De novo Stress Urinary Incontinence after Pelvic Floor Reconstruction: A Nested Case-control Study. Chin Med J (Engl) (2017) 0.75
The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data. Am Health Drug Benefits (2017) 0.75
Intrafascial versus extrafascial abdominal hysterectomy: effects on urinary urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.75
Left ventricular pseudoaneurysm. J Am Coll Cardiol (1998) 8.81
Efficacy of screening mammography. A meta-analysis. JAMA (1995) 6.94
Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA (1996) 6.53
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52
Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA (1996) 4.89
Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (2000) 4.05
Should we be measuring blood cholesterol levels in young adults? JAMA (1993) 3.57
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA (1996) 3.54
Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol (2001) 3.36
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35
Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA (1998) 3.32
Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol (1999) 3.19
Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst (1998) 3.08
Positive predictive value of screening mammography by age and family history of breast cancer. JAMA (1993) 2.95
Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet (2000) 2.82
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA (1995) 2.69
Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. JAMA (1996) 2.44
Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med (1996) 2.36
Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol (1999) 2.20
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol (1996) 2.09
Differences in socioeconomic status and survival among white and black men with prostate cancer. Am J Epidemiol (2000) 1.95
Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med (2001) 1.87
Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health (1998) 1.78
Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc (1998) 1.66
Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation (2001) 1.61
Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol (1996) 1.59
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol (2001) 1.56
The lumpy breast. West J Med (1988) 1.43
Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism. Am J Med (1998) 1.42
Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab (1996) 1.41
Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials. Cancer (1995) 1.39
Carpal tunnel syndrome. West J Med (1988) 1.38
Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial. West J Med (2001) 1.35
Preoperative intravenous fluid therapy decreases postoperative nausea and pain in high risk patients. Anesth Analg (2005) 1.29
The waning effect of postmenopausal estrogen therapy on osteoporosis. N Engl J Med (1993) 1.27
Antibiotics in acute bronchitis: a meta-analysis. Am J Med (1999) 1.24
Periodontal effects associated with the use of smokeless tobacco. J Periodontol (1990) 1.17
Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst (1997) 1.11
Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol (1998) 1.11
Design and methods of the Raloxifene Use for The Heart (RUTH) study. Am J Cardiol (2001) 1.10
The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2001) 1.09
Statins: underused by those who would benefit. BMJ (2000) 1.06
Effect of amoxicillin-clavulanate and cephradine on the fecal flora of healthy volunteers not exposed to a hospital environment. Antimicrob Agents Chemother (1986) 1.06
Postmenopausal hormone therapy for prevention of fractures: how good is the evidence? JAMA (2001) 1.04
Effects of urinary incontinence, comorbidity and race on quality of life outcomes in women. J Urol (2007) 1.01
Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? Study of Osteoporotic Fractures Research Group. Arch Intern Med (1995) 0.98
Facial wrinkling in men and women, by smoking status. Am J Public Health (1995) 0.97
Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Intern Med (2000) 0.96
Post-operative recovery: day surgery patients' preferences. Br J Anaesth (2001) 0.96
The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med (2000) 0.96
Research interests of physicians in two practice-based primary care research networks. West J Med (1999) 0.95
Domestic violence. Risk factors and outcomes. West J Med (1991) 0.93
Risk factor modification after myocardial infarction. Ann Intern Med (1988) 0.92
Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. J Am Coll Cardiol (2001) 0.92
Diagnosis and treatment of coronary heart disease in women: systematic reviews of evidence on selected topics. Evid Rep Technol Assess (Summ) (2003) 0.91
Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC). Gynecol Oncol (1998) 0.90
Molecular characterization of patients with 18q23 deletions. Am J Hum Genet (1997) 0.89
FISH analysis of terminal deletions in patients diagnosed with cri-du-chat syndrome. Clin Genet (1999) 0.88
Hormones to prevent coronary disease in women: when are observational studies adequate evidence? Ann Intern Med (2000) 0.87
Reagents which inhibit disulphide bond formation stabilize human fibroblast interferon. J Gen Virol (1977) 0.86
Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Evid Rep Technol Assess (Summ) (2003) 0.86
Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? Ann Intern Med (1990) 0.85
Development of diagnostic tools for the analysis of 5p deletions using interphase FISH. Cytogenet Cell Genet (1997) 0.85
Relationship between adhesion of Escherichia coli to uro-epithelial cells and the pathogenesis of urinary infection: problems in methodology and analysis. J Med Microbiol (1985) 0.85
Urinary incontinence and pelvic floor dysfunction in Asian-American women. Am J Obstet Gynecol (2006) 0.85
Physical analysis of the terminal 240 kb of DNA from human chromosome 7q. Genomics (1993) 0.84
Healthy give organs to dying, raising issues of risk and ethics. N Y Times Web (2001) 0.84
Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene. J Womens Health (1998) 0.84
Venous thromboembolic events associated with hormone replacement therapy. JAMA (1997) 0.83
A spit tobacco cessation intervention for college athletes: three-month results. Adv Dent Res (1997) 0.82
Risk stratification of ambulatory patients suspected of Pneumocystis pneumonia. Arch Intern Med (1991) 0.82
Teicoplanin in patients with chronic renal failure on dialysis: microbiological and pharmacokinetic aspects. Int J Clin Pharmacol Res (1987) 0.82
Insulin-like growth factor 1 and functional status in healthy older men. J Am Geriatr Soc (1995) 0.82
Left ventricular pseudoaneurysm: diagnosis by cine magnetic resonance imaging. Cardiology (1999) 0.81
Hospital is fined for "woeful care": Mt. Sinai cited for deficiencies after liver donor's death. N Y Times Web (2002) 0.81
Histamine synthesis by respiratory tract micro-organisms: possible role in pathogenicity. J Clin Pathol (1989) 0.80
The incidence of unrecognized myocardial infarction in women with coronary heart disease. Ann Intern Med (2001) 0.80
Smokeless tobacco use: how it affects the performance of major league baseball players. J Am Dent Assoc (1995) 0.79
Postmenopausal hormones and heart disease. J Am Coll Cardiol (2001) 0.79
Coronary heart disease in women, randomized clinical trials, HERS and RUTH. Maturitas (1998) 0.78
Treatment of hyperlipidemia in women. JAMA (1995) 0.77
Hormone treatment--misconceptions and agreements. Eur Heart J (2002) 0.77
Ascorbic acid supplement use and the prevalence of gallbladder disease. Heart & Estrogen-Progestin Replacement Study (HERS) Research Group. J Clin Epidemiol (1998) 0.77
A yeast artificial chromosome contig of the critical region for cri-du-chat syndrome. Genomics (1994) 0.77
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 0.76
Physical map and characterization of transcripts in the candidate interval for familial chondrocalcinosis at chromosome 5p15.1. Genomics (1999) 0.76
Association of Epstein-Barr virus with acute exudative tonsillitis. Otolaryngol Head Neck Surg (1982) 0.75
Postmenopausal hormone therapy--good for smokers? J Am Coll Cardiol (1999) 0.75
Exercise, hormone therapy, and lipoproteins in women. J Am Geriatr Soc (1996) 0.75
Ironing out the wrinkles in the prion strain problem. Science (1996) 0.75
Quick-change pathogens gain an evolutionary edge. Science (1996) 0.75
Meta-analyses and large randomized, controlled trials. N Engl J Med (1998) 0.75
Long-term follow-up of patients with biopsy-proven benign breast disease. Ann Surg (1989) 0.75
Pelvic floor disorders and quality of life in women with self-reported irritable bowel syndrome. Aliment Pharmacol Ther (2009) 0.75
The postmenopausal estrogen/breast cancer controversy. JAMA (1993) 0.75
Postmenopausal hormone therapy, SERMs, and coronary heart disease in women. J Endocrinol Invest (1999) 0.75